Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.
Babaei M, Pirnejad H, Rezaie J, Roshandel G, Hoseini R. Association between socioeconomic factors and the risk of gastric cancer incidence: results from an ecological study. Iran J Public Health. 2023;52(8):1739.
PubMed PubMed Central Google Scholar
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17–48.
Liu YP, Zheng CC, Huang YN, He ML, Xu WW, Li B. Molecular mechanisms of chemo-and radiotherapy resistance and the potential implications for cancer treatment. MedComm. 2021;2(3):315–40.
Article CAS PubMed PubMed Central Google Scholar
Bao Y, Liu S, Zhou Q, Cai P, Anfossi S, Li Q, Hu Y, Liu M, Fu J, Rong T. Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern. Radiat Oncol. 2013;8:1–8.
Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3(1):7.
Article PubMed PubMed Central Google Scholar
Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41–9.
Article CAS PubMed Google Scholar
Friedenstein A, Chailakhjan R, Lalykina K. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Prolif. 1970;3(4):393–403.
Klingemann H, Matzilevich D, Marchand J. Mesenchymal stem cells–sources and clinical applications. Transfus Med Hemother. 2008;35(4):272–7.
Article PubMed PubMed Central Google Scholar
Lan T, Luo M, Wei X. Mesenchymal stem/stromal cells in cancer therapy. J Hematol Oncol. 2021;14(1):1–16.
Salgado JA, Reis LR, Sousa N, Gimble MJ. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Current Stem Cell Res Ther. 2010;5(2):103–10.
Xi X-M, Xia S-J, Lu R. Drug loading techniques for exosome-based drug delivery systems. Die Pharmazie Int J Pharm Sci. 2021;76(2–3):61–7.
Gutierrez-Millan C, Calvo Díaz C, Lanao JM, Colino CI. Advances in exosomes-based drug delivery systems. Macromol Biosci. 2021;21(1):2000269.
Yang Z, Li Y, Wang Z. Recent advances in the application of mesenchymal stem cell-derived exosomes for cardiovascular and neurodegenerative disease therapies. Pharmaceutics. 2022;14(3):618.
Article CAS PubMed PubMed Central Google Scholar
Zargar MJ, Kaviani S, Vasei M, Soufi Zomorrod M, Heidari Keshel S, Soleimani M. Therapeutic role of mesenchymal stem cell-derived exosomes in respiratory disease. Stem Cell Res Ther. 2022;13(1):1–11.
Li X, Wang Y, Shi L, Li B, Li J, Wei Z, Lv H, Wu L, Zhang H, Yang B. Magnetic targeting enhances the cutaneous wound healing effects of human mesenchymal stem cell-derived iron oxide exosomes. Journal of nanobiotechnology. 2020;18:1–14.
Zhao C, Busch DJ, Vershel CP, Stachowiak JC. Multifunctional transmembrane protein ligands for cell-specific targeting of plasma membrane-derived vesicles. Small. 2016;12(28):3837–48.
Article CAS PubMed PubMed Central Google Scholar
Sánchez-Moreno P, Ortega-Vinuesa JL, Martín-Rodríguez A, Boulaiz H, Marchal-Corrales JA, Peula-García JM. Characterization of different functionalized lipidic nanocapsules as potential drug carriers. Int J Mol Sci. 2012;13(2):2405–24.
Article PubMed PubMed Central Google Scholar
Jafari H, Hassanpour M, Akbari A, Rezaie J, Gohari G, Mahdavinia GR, Jabbari E. Characterization of pH-sensitive chitosan/hydroxypropyl methylcellulose composite nanoparticles for delivery of melatonin in cancer therapy. Mater Lett. 2021;282: 128818.
Zafar S, Akhter S, Ahmad I, Hafeez Z, Rizvi MMA, Jain GK, Ahmad FJ. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of docetaxel and thymoquinone by chitosan grafted lipid nanocapsules: formulation optimization, in vitro and in vivo studies. Colloids Surf B. 2020;186: 110603.
Nabavinia M, Beltran-Huarac J. Recent progress in iron oxide nanoparticles as therapeutic magnetic agents for cancer treatment and tissue engineering. ACS Appl Bio Mater. 2020;3(12):8172–87.
Article CAS PubMed Google Scholar
García-Manrique P, Gutiérrez G, Blanco-López MC. Fully artificial exosomes: towards new theranostic biomaterials. Trends Biotechnol. 2018;36(1):10–4.
García-Manrique P, Matos M, Gutiérrez G, Pazos C, Blanco-López MC. Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes. J Extracell Vesicles. 2018;7(1):1422676.
Article PubMed PubMed Central Google Scholar
Akhavanakbari G, Babapour B, Alipour MR, Keyhanmanesh R, Ahmadi M, Aslani MR. Effect of high fat diet on NF-кB microRNA146a negative feedback loop in ovalbumin-sensitized rats. BioFactors. 2019;45(1):75–84.
Article CAS PubMed Google Scholar
Armstrong JP, Holme MN, Stevens MM. Re-engineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano. 2017;11(1):69–83.
Article CAS PubMed PubMed Central Google Scholar
Kanada M, Bachmann MH, Hardy JW, Frimannson DO, Bronsart L, Wang A, Sylvester MD, Schmidt TL, Kaspar RL, Butte MJ. Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci. 2015;112(12):E1433–42.
Article CAS PubMed PubMed Central Google Scholar
Sun Y, Liu G, Zhang K, Cao Q, Liu T, Li J. Mesenchymal stem cells-derived exosomes for drug delivery. Stem Cell Res Ther. 2021;12:1–15.
Lou G, Song X, Yang F, Wu S, Wang J, Chen Z, Liu Y. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8(1):1–11.
Article PubMed PubMed Central Google Scholar
Familtseva A, Jeremic N, Tyagi SC. Exosomes: cell-created drug delivery systems. Mol Cell Biochem. 2019;459:1–6.
Article CAS PubMed Google Scholar
Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Targeted delivery of doxorubicin to HER2 positive tumor models. Int J Nanomed. 2019;14:5679–90.
Jeyaram A, Lamichhane TN, Wang S, Zou L, Dahal E, Kronstadt SM, Levy D, Parajuli B, Knudsen DR, Chao W. Enhanced loading of functional miRNA cargo via pH gradient modification of extracellular vesicles. Mol Ther. 2020;28(3):975–85.
Article CAS PubMed Google Scholar
Huang X, Ding J, Li Y, Liu W, Ji J, Wang H, Wang X. Exosomes derived from PEDF modified adipose-derived mesenchymal stem cells ameliorate cerebral ischemia-reperfusion injury by regulation of autophagy and apoptosis. Exp Cell Res. 2018;371(1):269–77.
Article CAS PubMed Google Scholar
David A. Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment. Adv Drug Deliv Rev. 2017;119:120–42.
Article CAS PubMed Google Scholar
Wang X, Chen Y, Zhao Z, Meng Q, Yu Y, Sun J, Yang Z, Chen Y, Li J, Ma T. Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction. J Am Heart Assoc. 2018;7(15): e008737.
Article CAS PubMed PubMed Central Google Scholar
Tian T, Zhang H-X, He C-P, Fan S, Zhu Y-L, Qi C, Huang N-P, Xiao Z-D, Lu Z-H, Tannous BA. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137–49.
Article CAS PubMed Google Scholar
Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, Lee JJ, Kalluri R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503.
Article CAS PubMed PubMed Central Google Scholar
Yeo LY, Chang HC, Chan PP, Friend JR. Microfluidic devices for bioapplications. Small. 2011;7(1):12–48.
Article CAS PubMed Google Scholar
Tsui JH, Lee W, Pun SH, Kim J, Kim D-H. Microfluidics-assisted in vitro drug screening and carrier production. Adv Drug Deliv Rev. 2013;65(11–12):1575–88.
Comments (0)